Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Living in the dark: Gaza’s struggle for electricity - 2Dozens killed as Angola flood death toll rises
- 3Nutrient Rich Organic products: Lift Your Wellbeing
- 4Nordic people know how to beat the winter blues. Here's how to find light in the darkest months
- 5US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- Sunken warship found off Danish coast after 225 years in ‘remarkable’ discovery
- Figure out How to Augment Eco-friendliness in Your Volvo XC40
- Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- Instructions to Clean and Really focus on Your Lab Precious stone
- Haifa refinery said hit in latest Iranian missile barrage
- 7 Espresso Machines for Home Baristas
- Flat Earth, spirits and conspiracy theories – experience can shape even extraordinary beliefs
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
- Overlooked infertility care should be part of national health services, says WHO
